Overview

Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that...

Open

$0.00

Prior close

$36.91

Today's high

$0.00

Today's low

$0.00

52 Week high

$42.50

52 Week low

$19.30

News

MarketBeat • about 1 month ago • ROIV

Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months

GlobeNewsWire • about 1 month ago • ROIV

Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus

GlobeNewsWire • about 1 month ago • ROIV

Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus

Seeking Alpha • about 1 month ago • ROIV

Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • about 2 months ago • ROIV

Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants